FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
PMA: P190019
·
Supplement: S007
·
Decision Mar 15, 2021
Classifications
1
FEI Numbers
26
Registration Numbers
26
Basic Information
- Device Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Trade Name
- Ranger Over-The-Wire Paclitaxel-Coated PTA Balloon Catheter
- PMA Number
- P190019
- Supplement Number
- S007
- Device Class
- FDA Class 3
- Product Code
- ONU
- Generic Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- March 15, 2021
- Date Received
- February 24, 2021
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Addition of four stretchers.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| ONU | Drug-Eluting Peripheral Transluminal Angioplasty Catheter | FDA class 3 | Unknown |